相关实验视频
Updated: Jan 12, 2026

09:33
Methods to Classify Cytoplasmic Foci as Mammalian Stress Granules
Published on: May 12, 2017
15.0K
压力颗粒:编程细胞死亡的新型调节剂
Jiayi Xu1,2, Liangwen Yan2, Xinyan Li2
1Department of Critical Care Medicine, National & Local Joint Engineering Research Center of Biodiagnosis and Biotherapy, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Mini reviews in medicinal chemistry
|November 5, 2025
概括
在细胞应激过程中形成的压力颗粒 (SGs) 调节细胞死亡途径. 了解SG动态为与异常细胞死亡相关的疾病提供了新的治疗点.
科学领域:
- 细胞生物学 细胞生物学
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 应力颗粒 (SG) 是通过在细胞应力下通过液-液相分离 (LLPS) 形成的动态细胞质凝聚物.
- SGs充当信号枢纽,隔离mRNA,蛋白质和信号分子来协调细胞适应性反应.
- 失调的SG因干扰重要的细胞通路,包括压力诱导的细胞死亡,而与各种疾病有关.
研究的目的:
- 系统地审查压力颗粒动态和主要细胞死亡方式之间的关系.
- 阐明适应应激的SG蛋白质组如何影响细胞死亡途径的激活或抑制.
- 在SG和细胞死亡途径的接口处识别潜在的治疗点.
主要方法:
- 系统的文献综述和压力颗粒生物学和细胞死亡调节方面的最新进展的综合.
- 对蛋白质组数据的分析,将SG组件与细胞死亡调节器联系起来.
- 机理性检查SG参与的亡,死亡,烧亡和铁亡.
主要成果:
- 压力颗粒隔离了亡,亡,亡和铁亡的多个调节者.
- 根据细胞背景,SG动态可以促进或抑制不同的细胞死亡途径.
- SGs的组成和动态极大地影响了压力诱导的细胞死亡的结果.
结论:
- 压力颗粒在调节多种细胞死亡途径方面发挥着复杂的,取决于环境的作用.
- 针对SG死亡途径相互作用,为SG相关病理提供了一个有前途的治疗策略.
- 对细胞死亡机制SG治理的进一步研究对于开发新疗法至关重要.
相关概念视频
Overview of Cell Death
9.3K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
9.3K
The Extrinsic Apoptotic Pathway
8.0K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
Caspases
13.7K
Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
13.7K
The Intrinsic Apoptotic Pathway
8.2K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Apoptosis
14.0K
Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
14.0K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K

